Advaxis Combination Trial with Merck Completes First Two Dose-Escalation Cohorts
Go back to Advaxis Combination Trial with Merck Completes First Two Dose-Escalation Cohorts| ADVAXIS (AMEX: ADXS) | Delayed: 0.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $16.30 | |||
| Open | $0.60 | 52 Week Low | $5.21 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $-4.10 | |||
| Volume | 7,609,267 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 135.84 +0.29 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.55 | 52 Week High | $65.46 | |||
| Open | $134.43 | 52 Week Low | $47.97 | |||
| Day High | $135.97 | P/E | 92.41 | |||
| Day Low | $133.40 | EPS | $1.47 | |||
| Volume | 6,868,318 | |||||
